Συγγραφείς:
Cherny, N.I.
Dafni, U.
Bogaerts, J.
Latino, N.J.
Pentheroudakis, G.
Douillard, J.-Y.
Tabernero, J.
Zielinski, C.
Piccart, M.J.
de Vries, E.G.E.
Λέξεις-κλειδιά:
antineoplastic agent, drug approval; Food and Drug Administration; United States, Antineoplastic Agents; Drug Approval; United States; United States Food and Drug Administration
